PharmD Signal

Deep dives, evidence grades, and clinical tools, all in one place.

SEEP Consensus on Pediatric Type 1 Diabetes in Special Situations

SEEP consensus recommendationsSpanish Society of Pediatric Endocrinologytype 1 diabetesinsulinglucagonAID systemsCSIICGM Pediatric Pharmacy

Background Information

New consensus guides T1D management in special situations for children and adolescents.

Managing type 1 diabetes (T1D) in children and adolescents during special situations is crucial to prevent complications and optimize health outcomes. This guideline offers consensus recommendations based on the latest protocols from the International Society for Pediatric and Adolescent Diabetes (ISPAD) and the American Diabetes Association (ADA). The recommendations provide detailed guidance on treatment modalities to optimize glycemic control and manage acute complications in young patients with T1D. Updated consensus recommendations assist in managing young patients with T1D during special situations.

📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.

Authors: Gil Poch E, Ferrer Lozano M, Murillo Vallés M, Cardona-Hernandez R, Clemente León M, Itza Martín N, Leiva-Gea I, Pérez Sánchez J, Ros Pérez P, Bahillo Curieses MP

Citation: Gil Poch E, Ferrer Lozano M, Murillo Vallés M, et al. Clinical recommendations for the management of patients with type 1 diabetes in special situations. Anales de pediatria. 2026;105(2):504266. doi:10.1016/j.anpede.2026.504266

Article Links: PubMed · Journal / DOI

🎓
Reviewed by a licensed pharmacist
Every analysis is reviewed and approved by a licensed pharmacist before publication, ensuring clinical accuracy and relevance.
Accurate and up-to-date information is our highest priority.
If you spot an error, please suggest a correction. If there is a topic you want covered, tell us and we will look at it.
Thanks for the feedback!
🔒
Deep Analysis: Subscribers Only
Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.
Executive Summary
Study Design
Patient Population
Primary Outcomes
Secondary Outcomes & Safety Profile
Pharmacist Implications
Clinical Pearls
Limitations
Controversies & Evidence Gaps
Cost & Logistics
Founding member rate
$8/month. Cancel anytime.

One subscription unlocks this analysis and every other one we publish, plus Practice Signals, PDF reports, and GRADE evidence grades.

Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.
Or $79/year. Founding members keep this rate for as long as they stay subscribed. Cancel anytime from your Account page.